Mark Andrew White - 31 Oct 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Reporting relationship: General Manager, Commercial Affairs
Issuer ticker: RCKT
Reported as of: 31 Oct 2024
Net transaction value: -$51,205
SEC form: 4
Accepted by SEC: 04 Nov 2024, 16:06:07 UTC
Prior SEC filing: 09 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Martin Wilson, as attorney-in-fact for Mark Andrew White

Key filing fact

Mark Andrew White filed Form 4 for ROCKET PHARMACEUTICALS, INC. (RCKT) on 04 Nov 2024.

Key facts

This page summarizes Mark Andrew White's Form 4 filing for ROCKET PHARMACEUTICALS, INC. (RCKT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Nov 2024, 16:06.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

RCKT transaction

Sale

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 2 footnotes

Footnote F1

Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

Footnote F2

The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

SEC remarks

General Manager, Commercial Affairs